Xanthine Reprogramming of Tissue Stem Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reprogramming differentiated somatic cells to an undifferentiated stem cell-like state, such as producing induced pluripotent stem cells (iPSCs), are inefficient and time-consuming, often requiring the introduction of exogenous genes or proteins, which can lead to integration issues and ethical concerns, and have low transformation efficiency.
Innovation Solution
The method involves using xanthine (Xn) in a culture medium to suppress asymmetric cell kinetics, allowing tissue stem cells to expand and reprogram into a pluripotent state without the need for exogenous master transcription factors, increasing efficiency and speed by promoting symmetric self-renewal and expansion of stem cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If exogenous genes or proteins of master transcription factors are introduced into somatic cells to reprogram them, then reprogramming can be achieved, but transformation efficiency is low and the process is time-consuming
Solution Approach 1:
The invention extracts and eliminates the need for exogenous gene or protein introduction by utilizing small molecules (xanthine, xanthosine, or hypoxanthine) that can be taken up by cells through existing transport channels. This removes the complex transfection steps while achieving the same reprogramming effect, thereby improving efficiency and reducing time.
Solution Approach 2:
The invention changes the chemical parameters of the reprogramming approach by using small molecule compounds instead of biological macromolecules (genes or proteins). These small molecules can be directly taken up by cells and converted into intracellular nucleotides, altering the reprogramming mechanism from genetic manipulation to metabolic modulation, which significantly improves transformation efficiency and reduces processing time.
2Reliability
If multiple exogenous genes representing master transcription factors are introduced into somatic cells, then reprogramming can occur, but transformation efficiency decreases due to multiple plasmids
Solution Approach 1:
The invention merges the function of multiple master transcription factors (OCT3/4, SOX2, KLF4, c-MYC, NANOG, LIN28) into a single small molecule treatment regimen. Instead of introducing multiple separate genes or proteins, the small molecules collectively activate the endogenous expression of these factors, simplifying the process from multiple transfection steps to a single treatment protocol, thereby dramatically improving transformation efficiency.
Solution Approach 2:
The invention enables the cell's own machinery to perform the reprogramming by activating endogenous master transcription factors through small molecule stimulation. The cell utilizes its existing metabolic pathways and gene expression machinery to generate the necessary transcription factors internally, eliminating the need for external gene delivery and allowing the cell to self-reprogram, which significantly enhances transformation efficiency.
3Productivity
If viral vectors are used to transfect master transcription factors into somatic cells, then transduction efficiency improves, but the process still takes about four weeks and has integration issues
Solution Approach 1:
The invention extracts and removes the viral vector system entirely, replacing it with small molecule compounds that can be taken up by cells through existing nucleoside transport channels. This eliminates the complexity of viral production, safety concerns about integration, and the four-week timeline, while maintaining the ability to deliver reprogramming factors through a simpler, non-integrating mechanism.
Solution Approach 2:
The invention substitutes the mechanical/biological system of viral transduction with a chemical system using small molecules. Instead of relying on viral particles to deliver genetic material, the small molecules are taken up by cells and converted into intracellular nucleotides that naturally activate gene expression, replacing a complex biological delivery system with a simpler chemical approach that avoids integration issues.
4Stability of the object's composition
If exogenous genes are integrated into the somatic cell genome, then stable expression can be achieved, but integration issues and ethical concerns arise
Solution Approach 1:
The invention extracts and eliminates the genome integration step entirely by using small molecules that act transiently to activate endogenous gene expression. The small molecules are taken up by cells, converted to nucleotides, and stimulate transcription factor expression without requiring permanent genetic modification, thereby achieving stable expression during the reprogramming window while avoiding all integration-related harmful effects and ethical concerns.
Solution Approach 2:
The invention uses small molecule compounds as temporary, disposable reprogramming agents rather than permanent genetic modifications. These small molecules perform their function during the reprogramming process and are then metabolized or eliminated, leaving no permanent trace in the genome. This approach provides the necessary stable expression for reprogramming while avoiding the long-term complications and ethical issues associated with genomic integration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the efficient and rapid reprogramming of tissue stem cells into a pluripotent state, comparable to methods using gene or protein transfer, without the integration issues and ethical concerns, with xanthine acting as a guanine ribonucleotide precursor to enhance cellular guanine ribonucleotide pools and shift self-renewal kinetics.
Implementation Method 1
xanthine (Xn; the agent originally used to expand the adult stem cells by suppression of asymmetric cell kinetics)... As a guanine ribonucleotide precursor, Xn taken up from the medium expands guanine ribonucleotide pools
Data Source
AI summary
Embodied herein are methods of reprogramming somatic cells or tissue stem cells to a more multipotent state or even a pluripotent state, the methods do not involve gene transfer of master transcription factor genes/proteins. The methods are also useful for rapid and efficient cloning of induced pluripotent stem cells after gene transfer of master transcription factor genes/proteins.